Formerly known as MOFAS: Minnesota Organization on Fetal Alcohol Syndrome

Exciting News
from MOFAS

If you're looking for the Minnesota Organization on Fetal Alcohol Syndrome (MOFAS) you have come to the right place. We have some exciting news about our organization. We have a new name! MOFAS has officially been renamed Proof Alliance. Our mission remains the same: to prevent prenatal alcohol exposure and to improve the quality of life for people living with fetal alcohol spectrum disorders (FASD).

Why PR%F

We now have the proof that prenatal alcohol exposure is a leading cause of brain injury in children. We have the proof that FASD is 100% preventable and people living with an FASD can reach 100% of their potential.

Why Alliance?

We seek to build powerful alliances with people with an FASD, their families, legislators, experts in the field, new partners, and community members to bring awareness, research, and services to this field.

What's Next?

Proof Alliance is rebranding, expanding, and we're moving! We have a new logo, website, and prevention campaign to help change the norms around drinking during pregnancy. And in May 2019 we will be moving to a stand-alone building. Proof Alliance commits to the people of Minnesota and we will continue to develop transformative programs to help Minnesotans impacted by FASD.

Fetal Alcohol Spectrum Disorder – With Dr. Jeffrey Wozniak

Originally published: April 15, 2019 by NavNeuro

Today we give an overview of Fetal Alcohol Spectrum Disorder (FASD), which includes a collection of disorders that occur when a fetus is exposed to alcohol.  We discuss this topic with Jeffrey Wozniak, Ph.D., a neuropsychologist with extensive research and clinical experience in FASD, and cover the following areas:

  • Overview of the terminology used in FASD literature (2:48)
  • Prevalence of FASD and relevant descriptive statistics (5:19)
  • Maternal risk factors for FASD (6:14)
  • Threshold of drinking use (8:25)
  • Risk factors for FASD (9:43)
  • Are children with FASD protected under the Individuals with Disabilities Education Act and The Child Abuse Preventionand Treatment Act? (10:57)
  • Core terminology in the FASD literature (i.e., FAS, partial FAS, etc.) (12:06)
  • Should FASD be considered a neurobehavioral or neurodevelopmental disorder? (17:06)
  • Risk of false negatives (i.e., how to identify children with prenatal alcohol exposure who do not have FAS facial morphology) (18:31)
  • The relationship between alcohol and facial abnormalities (23:13)
  • Are neural tube abnormalities the mechanism of cognitive impairment in FASD? (26:19)
  • Neuropsychological battery and cognitive profile in FASD (29:15)
  • Risk factors for cognitive impairment (34:32)
  • Co-morbidities and differential diagnosis in neurodevelopmental disorders (36:25)
  • Overview of behavioral and neurocognitive deficits in FASD (38:36)
  • Neuroimaging and neurocognitive data in FASD (40:39)
  • Breast feeding in FASD (43:50)
  • Should a woman be concerned if she had one or two alcoholic beverages before knowing she was pregnant? (46:17)
  • Washington State Fetal Alcohol Spectrum Disorder Interagency Work Group (FASD IAWG) (48:12)
  • Treatment recommendations for FASD and important social/cultural factors to consider (i.e., low SES, foster care, low access to healthcare, etc.) (51:19)
  • Implications of intervention (55:00)
  • Implications of early screening (57:54)
  • The literature examining the efficacy of diagnosing FAS based on facial morphology (59:49)
  • FASD across the lifespan (1:03:02)
Share this page:

Support &

Women &

Training &